NCT01358877 A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer Status COMPLETED Phase PHASE3
NCT01327521 Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma Status WITHDRAWN Phase PHASE3
NCT01324141 Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer Status TERMINATED Phase PHASE1
NCT01308086 Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer Status UNKNOWN Phase PHASE3
NCT01246960 A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer Status COMPLETED Phase PHASE2
NCT01231802 Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer Status UNKNOWN Phase PHASE2
NCT01227707 A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. Status COMPLETED Phase PHASE2
NCT01226719 FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only Status COMPLETED Phase PHASE2
NCT01220128 Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer Status TERMINATED Phase PHASE2
NCT01216644 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT01206530 FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01183663 Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) Status COMPLETED Phase PHASE1
NCT01177956 A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck Status COMPLETED Phase PHASE3
NCT01150045 Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Status COMPLETED Phase PHASE3
NCT01121848 Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer Status COMPLETED Phase PHASE3
NCT01036087 Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer Status COMPLETED Phase PHASE2
NCT00995293 Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial Status COMPLETED Phase PHASE3